Spots Global Cancer Trial Database for crest
Every month we try and update this database with for crest cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis | NCT02228850 | Raynaud's Pheno... | Alprostadil Placebo | 18 Years - 79 Years | NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) | |
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer | NCT04165317 | Non-muscle Inva... | PF-06801591 Bacillus Calmet... | 18 Years - | Pfizer | |
Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis | NCT02228850 | Raynaud's Pheno... | Alprostadil Placebo | 18 Years - 79 Years | NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) |